Add to ORKGFacial angiofibromas are dermatological manifestations of tuberous sclerosis complex, a neurocutaneous disorder characterized by excess cell growth and proliferation. Oral rapamycin has been used to treat visceral tuberous sclerosis–related tumors; however, the side effect profile of this medicine precludes its routine use in patients lacking significant internal involvement. The authors formulated a novel rapamycin cream that is easy to compound and apply, does not cause local or systemic side effects, and results in a dramatic improvement of facial angiofibromas
<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>....
International audienceObjectives: In recent years, various formulations containing rapamycin, mainly...
<div><p>Background</p><p>Birt-Hogg-Dubé syndrome (BHD) is a rare autosomal dominant disorder charact...
Facial angiofibromas are dermatological manifestations of tuberous sclerosis complex, a neurocutaneo...
Facial angiofibromas, composed of fibrous tissue and blood vessels appearing on the face, are closel...
Abstract Background and Objectives: Facial angiofibromas are disfiguring facial lesions, present in ...
BACKGROUND: Tuberous sclerosis complex (TSC) is an autosomal dominant neurocutaneous syndrome causi...
Tuberous sclerosis complex (TSC) is a neurocutaneus disease that causes various other tumors includi...
Aim: Topical rapamycin for angiofibromas has been reported to be a new promising treatment. This stu...
Background and Objectives: Facial angiofibromas are disfiguring facial lesions, present in up to 80%...
The use of topical rapamycin or rapalog, an mTOR inhibitor, has shown promising results in treating ...
Background: The skin is one of the most affected organs in tuberous sclerosis complex and angiofibro...
International audienceWe report here the effect of topical rapamycin 1%, an efficient topical treatm...
Medicines for the treatment of rare diseases frequently do not attract the interest of the pharmaceu...
Tuberous Sclerosis Complex (TSC) is a rare autosomal dominant genetic disease caused by a deactivati...
<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>....
International audienceObjectives: In recent years, various formulations containing rapamycin, mainly...
<div><p>Background</p><p>Birt-Hogg-Dubé syndrome (BHD) is a rare autosomal dominant disorder charact...
Facial angiofibromas are dermatological manifestations of tuberous sclerosis complex, a neurocutaneo...
Facial angiofibromas, composed of fibrous tissue and blood vessels appearing on the face, are closel...
Abstract Background and Objectives: Facial angiofibromas are disfiguring facial lesions, present in ...
BACKGROUND: Tuberous sclerosis complex (TSC) is an autosomal dominant neurocutaneous syndrome causi...
Tuberous sclerosis complex (TSC) is a neurocutaneus disease that causes various other tumors includi...
Aim: Topical rapamycin for angiofibromas has been reported to be a new promising treatment. This stu...
Background and Objectives: Facial angiofibromas are disfiguring facial lesions, present in up to 80%...
The use of topical rapamycin or rapalog, an mTOR inhibitor, has shown promising results in treating ...
Background: The skin is one of the most affected organs in tuberous sclerosis complex and angiofibro...
International audienceWe report here the effect of topical rapamycin 1%, an efficient topical treatm...
Medicines for the treatment of rare diseases frequently do not attract the interest of the pharmaceu...
Tuberous Sclerosis Complex (TSC) is a rare autosomal dominant genetic disease caused by a deactivati...
<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>....
International audienceObjectives: In recent years, various formulations containing rapamycin, mainly...
<div><p>Background</p><p>Birt-Hogg-Dubé syndrome (BHD) is a rare autosomal dominant disorder charact...